About CaaMTech
CaaMTech is a company based in Issaquah (United States) founded in 2018 by Andrew Chadeayne.. CaaMTech has raised $23.35 million across 2 funding rounds from investors including Noetic Fund. The company has 7 employees as of December 31, 2024. CaaMTech offers products and services including Psychedelic Drug Research and 5-MeO-DMT Analog Development. CaaMTech operates in a competitive market with competitors including ATAI, COMPASS Pathways, MindMed, Beckley Psytech and Cybin, among others.
- Headquarter Issaquah, United States
- Employees 7 as on 31 Dec, 2024
- Founders Andrew Chadeayne
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Caamtech, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23.35 M (USD)
in 2 rounds
-
Latest Funding Round
$22 M (USD), Series A
Sep 08, 2021
- Investors
-
Employee Count
7
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CaaMTech
CaaMTech offers a comprehensive portfolio of products and services, including Psychedelic Drug Research and 5-MeO-DMT Analog Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Research on novel therapeutics for mental health via serotonin modulation.
Development of analogs targeting serotonin receptors for health applications.
Unlock access to complete
Unlock access to complete
Funding Insights of CaaMTech
CaaMTech has successfully raised a total of $23.35M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $22 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $22.0M
-
First Round
First Round
(01 Jun 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Series A - CaaMTech | Valuation | Noetic Psychedelic Fund |
|
| Jun, 2020 | Amount | Seed - CaaMTech | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CaaMTech
CaaMTech has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Noetic Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Noetic Fund is engaged in global investments in emerging health technologies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CaaMTech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CaaMTech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Caamtech Comparisons
Competitors of CaaMTech
CaaMTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ATAI, COMPASS Pathways, MindMed, Beckley Psytech and Cybin, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Therapies for mental disorders, including psilocybin for depression, are developed.
|
|
| domain | founded_year | HQ Location |
Psychedelic-based therapies for brain health disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of neurological and psychiatric disorders
|
|
| domain | founded_year | HQ Location |
Psychedelic therapeutics for psychiatric disorders are developed and provided.
|
|
| domain | founded_year | HQ Location |
Psychedelic-derived therapeutics for mental illnesses are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Caamtech
Frequently Asked Questions about CaaMTech
When was CaaMTech founded?
CaaMTech was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is CaaMTech located?
CaaMTech is headquartered in Issaquah, United States. It is registered at Issaquah, Washington, United States.
Who is the current CEO of CaaMTech?
Andrew Chadeayne is the current CEO of CaaMTech. They have also founded this company.
Is CaaMTech a funded company?
CaaMTech is a funded company, having raised a total of $23.35M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.35M, raised on Jun 01, 2020.
How many employees does CaaMTech have?
As of Dec 31, 2024, the latest employee count at CaaMTech is 7.
What does CaaMTech do?
CaaMTech was founded in 2018 and is based in Issaquah, United States. Operations focus on the biotechnology sector, where psychedelic drug discovery and research services are developed. Additional offerings include psychedelic formulations, drug safety and efficacy screening, intellectual property management to support funding, and technological innovations for advancement in the field.
Who are the top competitors of CaaMTech?
CaaMTech's top competitors include MindMed, COMPASS Pathways and Beckley Psytech.
What products or services does CaaMTech offer?
CaaMTech offers Psychedelic Drug Research and 5-MeO-DMT Analog Development.
Who are CaaMTech's investors?
CaaMTech has 1 investor. Key investors include Noetic Fund.